MAPT and Alzheimer disease: In gel staining of CyDPA2 with homogenized samples from an AD patient, a transgenic mouse that overexpresses tau, and recombinant phosphorylated and non-phosphorylated tau proteins supported the ability of this probe to detect hyperphosphorylated tau oligomers (Ramsden et al., 2005; Guerrero et al., 2009).